Three different questions can get mixed together
Solubility asks how much material dissolves under specified conditions. Absorption asks what reaches the body after ingestion. Clinical effectiveness asks what changes in a person, such as performance on a strength test. Each needs an appropriate measurement. A clear glass may illustrate a preparation characteristic, but it cannot stand in for the other two outcomes.
Hydrochloride and monohydrate are chemical forms. Micronized describes particle processing and can appear on a monohydrate label. This is why an advertisement comparing “HCl versus micronized” is already using unlike categories. Our micronization chapter provides the vocabulary needed to read that comparison more carefully.
The amount of a named compound on a label also should not be casually treated as an interchangeable amount of another compound. Do not multiply scoops or invent a ratio from an online discussion. A product's labeled serving is part of its instructions, not proof that it matches every protocol in the creatine literature.
What a direct training comparison found
Eghbali and colleagues published an eight-week trial in 2024 with 40 participants aged 18–25. Four groups of ten undertook resistance training while receiving HCl, monohydrate with a loading phase, monohydrate without loading, or placebo. The researchers measured strength, estimated body-composition outcomes and several hormone markers.
The study reported favorable changes in supplementation groups compared with placebo for several outcomes, but HCl did not show an advantage over monohydrate. The full paper declared no conflict of interest and acknowledged Japanese research support. It remains a small, short trial in young participants, with multiple measurements and specific training conditions.
That result is relevant to a claim of superiority. It does not prove every HCl product is ineffective, establish identical effects under all circumstances, or settle long-term use in adults over 50. “No superiority demonstrated here” is a more precise conclusion than “the two forms are guaranteed equivalent.”
A menopause study answers a different question
The CONCRET-MENOPA trial, published online in 2025, assigned 36 perimenopausal and menopausal women to three HCl-based interventions or placebo for eight weeks. One intervention also included creatine ethyl ester. The abstract described favorable findings for a middle-dose HCl group on selected measures, including reaction time and brain creatine.
There was no monohydrate comparison arm. The study therefore cannot show that HCl is better than monohydrate. Its mood-swing finding was reported at p=0.06, which should not be described as conventionally statistically significant. We reviewed the primary abstract; a full funding and detailed-methods assessment for this study was not completed here.
This is a frequent problem in product arguments: evidence that something differs from placebo becomes a claim that it beats another product never tested in the experiment. Write down the actual comparison groups before accepting a winner. Population relevance also helps, but a small study near a reader's age is still small.
Put newer studies beside the larger context
NIH's Office of Dietary Supplements describes monohydrate as the creatine form most widely studied and discusses the absence of demonstrated advantages for alternative forms in the evidence it reviews. That guidance supplies useful background, while individual newer studies need assessment on their own methods and dates.
The quantity of research alone is not a guarantee for a particular person. It does affect how much confidence a claim can reasonably carry. An established ingredient with many studies and a newer form with a few small experiments should not be presented as having equally developed evidence merely because both have citations on a sales page.
A paper's title or conclusion is a starting point, not a complete appraisal. Ask whether the result concerns a measured strength task, a blood marker, a questionnaire or a laboratory property. The creatine-without-training chapter uses the same approach to a different claim about what a supplement can accomplish by itself.
Price comparisons need a declared denominator
A container with smaller labeled servings may advertise more servings for the same package weight. That can be a valid label count without proving equivalent clinical value. Cost per manufacturer's serving answers a shopping question. Cost per gram of compound answers a different arithmetic question. Neither supplies a medically validated conversion between forms.
For a useful comparison, record the named ingredient, amount per serving, servings per container and full purchase price. Keep any extras or blends visible. If an HCl product includes other compounds, an outcome from that mixture cannot be credited automatically to HCl alone. The Transparent Labs review shows a similar attribution issue with a monohydrate blend.
Avoid presenting the cheapest number as the best result. A product can have a low cost per labeled serving and limited direct evidence for the outcome that matters to you. Our product comparison keeps commercial placement and documentary differences separate from clinical ranking.
Tolerance claims require their own evidence
A claim that one form prevents stomach discomfort needs comparative human tolerability data at relevant amounts. Solubility alone does not establish that result. The same applies to claims about water retention, kidney safety or “no loading required.” A sales phrase cannot replace a study designed to address the specific outcome.
If a supplement causes symptoms, increasing another form or changing amounts through trial and error is not the next step recommended here. Review the actual product and instructions with a healthcare professional. Include other supplements and medicines so the conversation addresses the whole situation, rather than just the ingredient name.
People arranging blood tests should also disclose creatine use. Our kidney blood-test chapter explains why a laboratory change needs clinical context. Changing chemical forms is not an established way to avoid that discussion or make a concerning result irrelevant.
A stronger way to read the next claim
Keep four questions together: what form was studied, who received it, what the comparison group received, and which outcome differed. Add the duration and funding information when available. These details help distinguish a genuine head-to-head finding from an attractive but unrelated citation.
For current HCl-versus-monohydrate decisions, the direct small training trial reviewed here did not demonstrate an HCl advantage, and the menopause trial cannot make that comparison. That leaves room for further research without creating a reason to assume superiority, invent dose equivalence or promise the same response for every shopper.
For a different alternative form, read the ethyl-ester trial chapter. It examines a direct three-group comparison, with blood, muscle and performance results kept separate.